Literature DB >> 1392827

Long term effects of tamoxifen on blood lipid values in breast cancer.

J A Dewar1, J M Horobin, P E Preece, R Tavendale, H Tunstall-Pedoe, R A Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1392827      PMCID： PMC1882673          DOI： 10.1136/bmj.305.6847.225

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.

Authors:  C C McDonald; H J Stewart
Journal:  BMJ       Date:  1991-08-24
  1 in total
  19 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

2.  Plasma proteomics analysis of tamoxifen resistance in breast cancer.

Authors:  Keivan Majidzadeh-A; Javad Gharechahi
Journal:  Med Oncol       Date:  2013-10-26       Impact factor: 3.064

Review 3.  Gonadal hormone substitutes: effects on the cardiovascular system.

Authors:  T B Clarkson; J M Cline; J K Williams; M S Anthony
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Effects of tamoxifen on serum lipid and apolipoprotein levels in postmenopausal patients with breast cancer.

Authors:  M Morales; N Santana; A Soria; A Mosquera; J Ordovás; J Nóvoa; P Betancor; P F Valerón; B Díaz-Chico; R Chirino
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production.

Authors:  D D Smith; X Tan; O Tawfik; G Milne; D J Stechschulte; K N Dileepan
Journal:  J Physiol Pharmacol       Date:  2010-06       Impact factor: 3.011

Review 6.  Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Authors:  F Khosrow-Khavar; K B Filion; S Al-Qurashi; N Torabi; N Bouganim; S Suissa; L Azoulay
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

Review 7.  Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.

Authors:  I A Mustafa; K I Bland
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

Review 8.  Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.

Authors:  Michel G Khouri; Pamela S Douglas; John R Mackey; Miguel Martin; Jessica M Scott; Marielle Scherrer-Crosbie; Lee W Jones
Journal:  Circulation       Date:  2012-12-04       Impact factor: 29.690

9.  Protective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?

Authors:  H Wiseman; G Paganga; C Rice-Evans; B Halliwell
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

10.  Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group.

Authors:  C C McDonald; F E Alexander; B W Whyte; A P Forrest; H J Stewart
Journal:  BMJ       Date:  1995-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.